1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Radioembolization Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Radioembolization Therapy Market, by Product Type
8.1.1. Yttrium-90 Microspheres
8.1.1.1. Market Revenue and Forecast
8.1.2. Holmium-166 Microspheres
8.1.2.1. Market Revenue and Forecast
8.1.3. Other Radioactive Microspheres
8.1.3.1. Market Revenue and Forecast
9.1. Radioembolization Therapy Market, by Procedure Type
9.1.1. Selective Internal Radiation Therapy
9.1.1.1. Market Revenue and Forecast
9.1.2. Whole Liver Radioembolization
9.1.2.1. Market Revenue and Forecast
9.1.3. Segmental Radioembolization
9.1.3.1. Market Revenue and Forecast
10.1. Radioembolization Therapy Market, by Technology
10.1.1. Trans Arterial Radioembolization
10.1.1.1. Market Revenue and Forecast
10.1.2. Selective Internal Radiation Therapy
10.1.2.1. Market Revenue and Forecast
11.1. Radioembolization Therapy Market, by Application
11.1.1. Primary Liver Cancer
11.1.1.1. Market Revenue and Forecast
11.1.2. Metastatic Liver Cancer
11.1.2.1. Market Revenue and Forecast
11.1.3. Other Cancers
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type
12.1.2. Market Revenue and Forecast, by Procedure Type
12.1.3. Market Revenue and Forecast, by Technology
12.1.4. Market Revenue and Forecast, by Application
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type
12.1.5.2. Market Revenue and Forecast, by Procedure Type
12.1.5.3. Market Revenue and Forecast, by Technology
12.1.5.4. Market Revenue and Forecast, by Application
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type
12.1.6.2. Market Revenue and Forecast, by Procedure Type
12.1.6.3. Market Revenue and Forecast, by Technology
12.1.6.4. Market Revenue and Forecast, by Application
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type
12.2.2. Market Revenue and Forecast, by Procedure Type
12.2.3. Market Revenue and Forecast, by Technology
12.2.4. Market Revenue and Forecast, by Application
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type
12.2.5.2. Market Revenue and Forecast, by Procedure Type
12.2.5.3. Market Revenue and Forecast, by Technology
12.2.5.4. Market Revenue and Forecast, by Application
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type
12.2.6.2. Market Revenue and Forecast, by Procedure Type
12.2.6.3. Market Revenue and Forecast, by Technology
12.2.6.4. Market Revenue and Forecast, by Application
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type
12.2.7.2. Market Revenue and Forecast, by Procedure Type
12.2.7.3. Market Revenue and Forecast, by Technology
12.2.7.4. Market Revenue and Forecast, by Application
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type
12.2.8.2. Market Revenue and Forecast, by Procedure Type
12.2.8.3. Market Revenue and Forecast, by Technology
12.2.8.4. Market Revenue and Forecast, by Application
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type
12.3.2. Market Revenue and Forecast, by Procedure Type
12.3.3. Market Revenue and Forecast, by Technology
12.3.4. Market Revenue and Forecast, by Application
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type
12.3.5.2. Market Revenue and Forecast, by Procedure Type
12.3.5.3. Market Revenue and Forecast, by Technology
12.3.5.4. Market Revenue and Forecast, by Application
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type
12.3.6.2. Market Revenue and Forecast, by Procedure Type
12.3.6.3. Market Revenue and Forecast, by Technology
12.3.6.4. Market Revenue and Forecast, by Application
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type
12.3.7.2. Market Revenue and Forecast, by Procedure Type
12.3.7.3. Market Revenue and Forecast, by Technology
12.3.7.4. Market Revenue and Forecast, by Application
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type
12.3.8.2. Market Revenue and Forecast, by Procedure Type
12.3.8.3. Market Revenue and Forecast, by Technology
12.3.8.4. Market Revenue and Forecast, by Application
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type
12.4.2. Market Revenue and Forecast, by Procedure Type
12.4.3. Market Revenue and Forecast, by Technology
12.4.4. Market Revenue and Forecast, by Application
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type
12.4.5.2. Market Revenue and Forecast, by Procedure Type
12.4.5.3. Market Revenue and Forecast, by Technology
12.4.5.4. Market Revenue and Forecast, by Application
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type
12.4.6.2. Market Revenue and Forecast, by Procedure Type
12.4.6.3. Market Revenue and Forecast, by Technology
12.4.6.4. Market Revenue and Forecast, by Application
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type
12.4.7.2. Market Revenue and Forecast, by Procedure Type
12.4.7.3. Market Revenue and Forecast, by Technology
12.4.7.4. Market Revenue and Forecast, by Application
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type
12.4.8.2. Market Revenue and Forecast, by Procedure Type
12.4.8.3. Market Revenue and Forecast, by Technology
12.4.8.4. Market Revenue and Forecast, by Application
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type
12.5.2. Market Revenue and Forecast, by Procedure Type
12.5.3. Market Revenue and Forecast, by Technology
12.5.4. Market Revenue and Forecast, by Application
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type
12.5.5.2. Market Revenue and Forecast, by Procedure Type
12.5.5.3. Market Revenue and Forecast, by Technology
12.5.5.4. Market Revenue and Forecast, by Application
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type
12.5.6.2. Market Revenue and Forecast, by Procedure Type
12.5.6.3. Market Revenue and Forecast, by Technology
12.5.6.4. Market Revenue and Forecast, by Application
13.1. Sirtex Medical
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Boston Scientific Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Terumo Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Merit Medical Systems, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. ABK Biomedical Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. TriSalus Life Sciences
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Guerbet
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Nordion Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Varian Medical Systems
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. China Grand Pharmaceutical and Healthcare Holdings
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
